Occudo Quantitative Strategies’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Occudo Quantitative Strategies’s Portfolio PHAS Stock Details PHAS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$45K	Sell
2021 Q4	$88K	Buy
2021 Q3	$92K	Buy
2021 Q2	$55K	Buy